GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...

If Robert F. Kennedy Jr. and the Trump administration want to make America healthy again, they should let Medicare cover ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...